With Segra, you can guarantee that you have the plant you want, when you want it, performing at its absolute best.
From plantlets to diagnostics, Segra’s specialized services drive growth for our partners.
Whether using your own genetics, or sampling cultivars from Segra’s exclusive library, Plant Tissue Culture can make your operation more efficient and profitable while reducing risk.Learn More
Our genetic identification technologies provide unparalleled quality assurance. With industry-pioneering and proprietary DNA Fingerprinting, Segra can help you grow with certainty.Learn More
Optimize your genetic portfolio with disease-free stock from Segra’s continuously expanding library of cannabis cultivars, curated by some of the industry’s leading genetic providers.Learn More
Creating better plants starts with innovation.
Bringing another key ag-tech tool to the cannabis playbook.
Segra has the unparalleled capacity to perform thousands of tests in-house each year to ensure that our plantlets are disease-free when they hit soil or leave our facility. We have developed best-in-class proprietary diagnostics tools that quickly and accurately identify the microbial cannabis pathogens that commonly affect nursery stock, including Botrytis cinereal, Phytopthora infestans, Sclerotinia sclerortiorum, Fusarium oxysporum, and are working on making these commercially available to growers to provide crucial insight into what’s happening at your operation when you need it the most.
Segra is working to develop one of our most trusted in-house tools into a decisive resource for growers.
Segra is a Plant Tissue Culture leader driving ag-tech innovation in the cannabis industry.
Under the guidance of Dr. Sma Zobayed, Segra’s Plant Tissue Culture Division is pioneering the future of cannabis tissue culture and young plant production. Segra’s flagship facility consists of state-of-the-art tissue culture production and research facilities, focused on the development of IP related to cannabis tissue culture protocols, micropropagation automation, and full-scale production testing from plantlet through flower.
This business division is led by Segra’s Chief Science Officer Dr. John Brunstein. Over the past 5 years, Segra has developed industry-leading quality assurance diagnostics for both cultivar DNA fingerprinting and pathogen detection. Research initiatives are focused on the development of IP related to genomics tools, bioinformatics systems, and marker assisted selection breeding programs.
The future of cannabis, today.